2017 Preliminary Conference Program

Please note that events and times are subject to change.


Wednesday, September 6, 2017  

10:45 am - 11:00 am

Welcome

11:00 am - 12:30 pm

Session 1: Neoantigens

Ugur Sahin, BioNTech, Mainz/Germany
Robert Schreiber, Washington University School of Medicine
Ton Schumacher, The Netherlands Cancer Institute

Lunch                                                                         12:30 pm - 1:30 pm

 1:30 pm - 3:30 pm

Session 1: Neoantigens continued

Catherine Wu, Dana-Farber Cancer Institute
Sine Reker Hadrup, Technical University of Denmark
Timothy Chan, Memorial Sloan Kettering Cancer Center
Proffered presentations to be selected from submitted abstracts

Refreshment Break                                                    3:30 pm - 4:00pm

 4:00 pm - 6:00 pm

Session 2: Novel mechanisms of immunosuppression and immune evasion

Nicholas Restifo, National Cancer Institute
Padmanee Sharma, MD Anderson Cancer Center
Jesse Zaretsky, UCLA Medical Center
Proffered presentations to be selected from submitted abstracts

6:00 pm - 8:00 pm

Reception and Poster Session A


Thursday, September 7, 2017

8:00 am - 10:00 am

Session 3: Tissue biomarkers predicting response to therapy 

Thomas Tüting, University Hospital Magdeburg
Drew Pardoll, Johns Hopkins University
Wolf Hervé Fridman, Cordeliers Research Centre
Proffered presentations to be selected from submitted abstracts

Refreshment Break                                                   10:00 am - 10:30 am

10:30 am - 12:30 pm

Session 4: Novel agents

Ignacio Melero, Universidad de Navarra
Özlem Türeci, Ci3-Cluster for Individualized Immune Intervention
Patrick Baeuerle, MPM Capital/TCR² Therapeutics
Proffered presentations to be selected from submitted abstracts

Lunch                                                                        12:30 pm - 2:00pm

2:00 pm - 3:30 pm

Session 5: Adoptive cell therapies

Hyam Levitsky, Juno Therapeutics
Dirk Busch, Technical University Munich
Renier Brentjens, Memorial Sloan Kettering Cancer Center

Refreshment Break                                                  3:30 pm - 4:00 pm

4:00 pm - 5:00 pm

Session 5: Adoptive cell therapies continued

Michael Jensen, Seattle Children's Research Institute
Proffered presentations to be selected from submitted abstracts

5:00 pm - 5:45 pm

William B. Coley Lecture


FRIDAY, September 8, 2017

8:00 am - 10:00 am

Session 6:  Combination therapies

Ira Mellman, Genentech
Sjoerd van der Burg, Leiden University Medical Center
Alexander Eggermont, Institut Gustave Roussy
Proffered presentations to be selected from submitted abstracts

Refreshment Break                                                  10:00 am - 10:30 am

10:30 am - 12:30 pm

Session 7:  Novel approaches for checkpoint blockade failure

George Coukos, Ludwig Institute for Cancer Research
Alexander Rudensky, Memorial Sloan Kettering Cancer Center
Sergio Quezada, University College London
Proffered presentations to be selected from submitted abstracts

Lunch                                                                        12:00 pm - 2:00 pm

Session 8:  Microbiota                                              2:00 pm - 3:15 pm

Laurence Zitvogel, Institut Gustave Roussy
Giorgio Trinchieri, National Institutes of Health
Proffered presentations to be selected from submitted abstracts

Refreshment Break                                                   3:30 pm - 4:00 pm

Session 9:  Other checkpoint blocking and           4:00 pm - 5:30 pm
immunomodulating antibodies 

Charles Drake, Columbia University Medical Center
Ana Anderson, Harvard Medical School
Martin Glennie, University of Southampton                                        

Keynote Lecture                                                         5:30 pm - 6:15 pm

Alberto Mantovani, Humanitas University

Reception and Poster Session B                               6:15 pm - 8:30 pm


Saturday, September 9, 2017

8:00 am - 10:00 am

Session 10: Therapy against hostile elements in the cancer microenvironment

Dmitry Gabrilovich, Wistar Institute
Serge Fuchs, University of Pennsylvania
Yousef Zahkaria, University of Iowa
Proffered presentations to be selected from submitted abstracts.

10:30 am - 12:15 pm

Session 11: Oncolytic viruses

John Bell, Ottawa Hospital Research Institute
Pedro Beltran, Amgen
Stephen Russell, Mayo Clinic
Proffered presentations to be selected from submitted abstracts